Addus HomeCare Corporation Completes Acquisition of Gentiva's Personal Care Operations
Deal News | Dec 11, 2024 | TT Capital Partners LLC
The healthcare industry is witnessing rapid changes, with significant mergers, acquisitions, and investments shaping its future. Recent transactions highlighted by TripleTree's Healthcare M&A Weekly include Addus HomeCare Corporation's acquisition of Gentiva's personal care operations, expanding Addus's service area across multiple states. Ampersand Capital Partners finalized their acquisition of Nektar Therapeutics' PEGylation reagent business, now branded Gannet Biochem. More transactions include Aya Healthcare's definitive agreement with Cross Country Healthcare, valued at $615 million, and CuraLinc Healthcare's acquisition of Wellspring Family Services’ EAP, supported by Lightyear Capital. Other notable deals involve CareSource, CoachCare, Neurotone AI, and Northwest Urgent Care, among others. These deals indicate a trend of increasing integration between healthcare technology and services, fostering innovation and improved patient outcomes.
Sectors
- Healthcare
- Private Equity and Investment
Geography
- United States – The majority of the transactions involve U.S. companies and entities such as Addus HomeCare, Aya Healthcare, and Ampersand Capital Partners, reflecting significant M&A activities within the US healthcare market.
- United Kingdom – Growth Catalyst Partners’ acquisition of U.K.-based InspiredMinds! introduces a cross-border dimension to the transactions, extending the geographic focus to include international influences in healthcare and tech.
Industry
- Healthcare – The article discusses multiple transactions and partnerships within the healthcare industry, illustrating the dynamic and evolving nature of healthcare services, technology, and patient care strategies.
- Private Equity and Investment – The involvement of various private equity firms such as Ampersand Capital Partners, ASH Investment Partners, and Growth Catalyst Partners in several transactions highlights the role of investment strategies in shaping industry trends.
Financials
- $615M – The valuation of the acquisition deal between Aya Healthcare and Cross Country Healthcare.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Addus HomeCare Corporation | Buyer | Company | A provider of in-home personal care services that completed the acquisition of Gentiva's personal care operations. |
| Gentiva | Target | Company | Offers personal care operations acquired by Addus HomeCare Corporation. |
| Ampersand Capital Partners | Buyer | Company | Private equity firm that acquired Nektar Therapeutics' PEGylation reagent manufacturing business. |
| Nektar Therapeutics | Target | Company | Provides PEGylation reagent manufacturing business acquired by Ampersand Capital Partners. |
| Aya Healthcare | Buyer | Company | Engaged in a definitive agreement to acquire Cross Country Healthcare for $18.61 per share. |
| Cross Country Healthcare | Target | Company | Provider to be acquired by Aya Healthcare in a transaction valued at approximately $615M. |
| CuraLinc Healthcare | Buyer | Company | Acquired the employee assistance program from Wellspring Family Services. |
| Wellspring Family Services | Target | Company | Seattle-based nonprofit provider of employee assistance programs acquired by CuraLinc Healthcare. |
| Lightyear Capital | Investor | Company | Primary investor supporting CuraLinc Healthcare's acquisition endeavors. |
| Growth Catalyst Partners | Buyer | Company | Acquired U.K.-based InspiredMinds!, focusing on AI4Good in healthcare. |
| InspiredMinds! | Target | Company | UK-based global tech and science strategy group focused on healthcare AI initiatives. |